|
|
|
|
94TH GENERAL ASSEMBLY
State of Illinois
2005 and 2006
SB2432
Introduced 1/18/2006, by Sen. John J. Cullerton SYNOPSIS AS INTRODUCED:
|
|
305 ILCS 5/5-5.12 |
from Ch. 23, par. 5-5.12 |
|
Amends the Illinois Public Aid Code. In provisions concerning the Medicaid program, provides that the Department of Healthcare and Family Services may not impose requirements for prior approval
based on a preferred drug list for anti-retroviral, anti-hemophilic factor
concentrates,
or
any atypical antipsychotics, conventional antipsychotics,
or anticonvulsants used for the treatment of serious mental
illnesses (instead of providing that the Department may not impose such requirements until 30 days after it has conducted a study of the impact of such
requirements on patient care and submitted a report to the Speaker of the
House of Representatives and the President of the Senate). Effective immediately.
|
| |
|
|
| FISCAL NOTE ACT MAY APPLY | |
|
|
|
A BILL FOR
|
|
|
|
|
SB2432 |
|
LRB094 15366 DRJ 50557 b |
|
|
| 1 |
| AN ACT concerning public aid.
|
| 2 |
| Be it enacted by the People of the State of Illinois,
|
| 3 |
| represented in the General Assembly:
|
| 4 |
| Section 5. The Illinois Public Aid Code is amended by |
| 5 |
| changing Section 5-5.12 as follows:
|
| 6 |
| (305 ILCS 5/5-5.12) (from Ch. 23, par. 5-5.12)
|
| 7 |
| Sec. 5-5.12. Pharmacy payments.
|
| 8 |
| (a) Every request submitted by a pharmacy for reimbursement |
| 9 |
| under this
Article for prescription drugs provided to a |
| 10 |
| recipient of aid under this
Article shall include the name of |
| 11 |
| the prescriber or an acceptable
identification number as |
| 12 |
| established by the Department.
|
| 13 |
| (b) Pharmacies providing prescription drugs under
this |
| 14 |
| Article shall be reimbursed at a rate which shall include
a |
| 15 |
| professional dispensing fee as determined by the Illinois
|
| 16 |
| Department, plus the current acquisition cost of the |
| 17 |
| prescription
drug dispensed. The Illinois Department shall |
| 18 |
| update its
information on the acquisition costs of all |
| 19 |
| prescription drugs
no less frequently than every 30 days. |
| 20 |
| However, the Illinois
Department may set the rate of |
| 21 |
| reimbursement for the acquisition
cost, by rule, at a |
| 22 |
| percentage of the current average wholesale
acquisition cost.
|
| 23 |
| (c) (Blank).
|
| 24 |
| (d) The Department shall not impose requirements for prior |
| 25 |
| approval
based on a preferred drug list for anti-retroviral, |
| 26 |
| anti-hemophilic factor
concentrates,
or
any atypical |
| 27 |
| antipsychotics, conventional antipsychotics,
or |
| 28 |
| anticonvulsants used for the treatment of serious mental
|
| 29 |
| illnesses
until 30 days after it has conducted a study of the |
| 30 |
| impact of such
requirements on patient care and submitted a |
| 31 |
| report to the Speaker of the
House of Representatives and the |
| 32 |
| President of the Senate.
|